Susquehanna International Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Buy |
|
|||||
|
2025
Q1 | $602K | Buy |
|
|||||
|
2024
Q4 | $247K | Buy |
|
|||||
|
2024
Q3 | $206K | Buy |
|
|||||
|
2024
Q2 | $159K | Sell |
|
|||||
|
2024
Q1 | $236K | Sell |
|
|||||
|
2023
Q4 | $330K | Buy |
|
|||||
|
2023
Q3 | $104K | Sell |
|
|||||
|
2023
Q2 | $540K | Buy |
|
|||||
|
2023
Q1 | $268K | Sell |
|
|||||
|
2022
Q4 | $725K | Buy |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $185K | Sell |
|
|||||
|
2021
Q4 | $402K | Sell |
|
|||||
|
2021
Q3 | $713K | Buy |
|
|||||
|
2021
Q2 | $912K | Sell |
|
|||||
|
2021
Q1 | $1.7M | Sell |
|
|||||
|
2020
Q4 | $1.44M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $521K | Sell |
|
|||||
|
2019
Q1 | $1.38M | Buy |
|
|||||
|
2018
Q4 | $944K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $43K | Buy |
|